4-methylcatechol, a potent inducer of nerve growth factor synthesis, protects spiral ganglion neurons from aminoglycoside ototoxicity--preliminary report

Acta Otolaryngol Suppl. 1999:540:12-5. doi: 10.1080/00016489950181125.

Abstract

The degeneration of spiral ganglion neurons after hair cell destruction following aminoglycoside ototoxicity is associated not only with the direct effect on the neurons, but also with a loss of neurotrophic factors provided by auditory hair cells. The neurotrophic factors, including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), have been reported to be effective in enhancing neuronal survival against aminoglycoside ototoxicity in vivo. To determine whether 4-methylcatechol (4-MC), a potent inducer of nerve growth factor synthesis, can protect spiral ganglion neurons after aminoglycoside treatment in vivo, we studied the spiral ganglion neurons of gentamicin (GM)-treated mice with or without 4-MC administration. We found that the number of surviving spiral ganglion neurons of 4-MC-treated animals was significantly greater than for those treated with GM alone. Our results suggest that 4-MC promotes synthesis of NGF (and/or other neurotrophins), which enhances spiral ganglion neuron survival after gentamicin treatment.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / toxicity*
  • Brain-Derived Neurotrophic Factor / biosynthesis
  • Catechols / pharmacology*
  • Female
  • Gentamicins / toxicity*
  • Male
  • Mice
  • Nerve Growth Factors / biosynthesis
  • Neurons / drug effects
  • Neuroprotective Agents / pharmacology*
  • Spiral Ganglion / cytology
  • Spiral Ganglion / drug effects*

Substances

  • Anti-Bacterial Agents
  • Brain-Derived Neurotrophic Factor
  • Catechols
  • Gentamicins
  • Nerve Growth Factors
  • Neuroprotective Agents
  • 4-methylcatechol